Med One Capital and Signostics are pleased to announce they have joined forces to provide clinicians with the latest in portable ultrasound technology coupled with customized financial options aimed at eliminating budgetary restraints and paving the way for immediate adoption. 

In early May 2016, Signostics launched its newest technology at the American Urological Association meeting. When the attendees indicated an immediate need for financing it brought the two companies together, allowing acute care and private practices to move forward rapidly with this unmatched portable ultrasound technology.

Robb Stevens, SVP of Leasing Sales at Med One Capital, said, “We look forward to working with the Signostics team to provide our 25-plus years of experience financing medical technologies for healthcare providers. We recognize the value of this new technology and believe that together we can provide a simple and easy solutions for any customer to acquire it.”

Signostics VP of Sales, Ryan Detzel said, “We recognized that many customers would see immediate value in USCAN but would need help in finding the budget. Med One Capital was our number one choice based on their knowledge of our customers’ needs and their reputation for being committed to helping healthcare providers access new technology, as well as their simple and easy to understand process.”